Clinical Trial Update: Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the effect of losartan on cardiovascular outcomes in patients with Mucopolysaccharidosis IV A and VI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morquio Syndrome
• Mucopolysaccharidosis Iv
• Mucopolysaccharidosis Vi

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Mucopolysaccharidosis IV A, Mucopolysaccharidosis VI | Phase 2 | Status: UNKNOWN